Margaret Wolff
About Margaret L. Wolff
Independent Board Member of Nuveen Core Equity Alpha Fund (JCE). Born 1955; joined Nuveen Funds boards in 2016. Former Skadden Mergers & Acquisitions attorney (Of Counsel 2005–2014) with deep governance and fiduciary advisory experience; BA Mt. Holyoke College; JD Case Western Reserve University School of Law .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Skadden, Arps, Slate, Meagher & Flom LLP | Of Counsel, M&A Group | 2005–2014 | Advised boards and senior management on governance, fiduciary, shareholder and strategic matters . |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| New York-Presbyterian Hospital | Trustee | Since 2005 | Healthcare nonprofit governance . |
| The John A. Hartford Foundation | Trustee; Chair (former) | Since 2004; Chair 2015–2022 | Philanthropy focused on care of older adults . |
| Mount Holyoke College | Trustee; Vice Chair (former) | 2005–2015; Vice Chair 2011–2015 | Higher education governance . |
| Travelers Insurance Co. of Canada; The Dominion of Canada General Insurance Co. | Director (subsidiaries of Travelers Canada) | 2013–2017 | Insurance subsidiaries; not current . |
Board Governance
- Independence: All nominees and continuing Board Members are “not interested persons” of the Funds or Adviser; deemed Independent Board Members .
- JCE election/term: Class I nominee for election by all shareholders to a term expiring at the 2028 annual meeting (funds without preferred shares) .
- Committee assignments:
- Audit Committee: Member (Audit committee includes independent members; financial experts designated are Moschner, Nelson, Starr, Young; Wolff not designated) .
- Compliance, Risk Management & Regulatory Oversight Committee: Chair .
- Nominating & Governance Committee: Member .
- Investment Committee: Member .
- Closed-End Fund Committee: Member .
- Attendance: Each Board Member attended at least 75% of Board and applicable committee meetings in the last fiscal year .
- Meetings (JCE last fiscal year): Regular Board 5; Special Board 9; Executive 5; Dividend 10; Compliance 5; Audit 14; Nominating & Governance 5; Investment 4; Closed-End 4 .
Fixed Compensation
- Structure (effective Jan 1, 2024; updated Jan 1, 2025):
- Annual retainer: $350,000; Chair of Board $150,000 (Wolff is not the Board Chair) .
- Committee membership retainers (2025): Audit $35,000; Compliance $35,000; Investment $30,000; Nominating & Governance $25,000; Closed-End Funds $25,000; Dividend $25,000 (Wolff not listed on Dividend) .
- Committee chair retainers (2025): Audit/Compliance $35,000; Investment $30,000; Dividend/Nominating/Closed-End $25,000 .
- Ad hoc/special assignment fees: $1,000/$2,500 per meeting; Chair quarterly fee starting at $1,250; members quarterly fee starting at $5,000 .
- Actual compensation paid (last fiscal year):
- JCE (Core Equity Alpha) allocation to Wolff: $724 .
- Total compensation from funds in the Nuveen Fund Complex paid to Wolff: $535,644 .
| Component | 2025 Rate | Wolff Status |
|---|---|---|
| Annual retainer | $350,000 | Receives |
| Audit Committee membership | $35,000 | Member |
| Compliance Committee membership | $35,000 | Member |
| Compliance Committee chair | $35,000 | Chair |
| Investment Committee membership | $30,000 | Member |
| Nominating & Governance membership | $25,000 | Member |
| Closed-End Funds membership | $25,000 | Member |
| Dividend Committee membership | $25,000 | Not listed |
| Ad hoc/special assignment | $1,000–$2,500 per meeting; chair/member quarterly fees as noted | As convened |
Performance Compensation
- Equity grants, RSUs/PSUs, options: None disclosed for independent trustees; no equity-based awards or options .
- Deferred Compensation Plan: Independent Board Members may elect to defer fees; deferrals tracked to the value of selected Nuveen funds; distributed lump sum or over 2–20 years .
- Wolff’s deferred fees (examples):
- JCE (Core Equity Alpha): $254 deferred fees (includes assumed investment return) .
- Preferred & Income Opportunities: $4,275 .
- NASDAQ 100 Dynamic Overwrite: $1,417 .
- S&P Buy-Write: $1,678 .
| Metric | 2025 Policy | Wolff |
|---|---|---|
| Equity/Option awards | Not part of director pay | None |
| Deferred compensation election | Allowed; book reserve account tracking fund shares; flexible payout | Multiple fund deferrals including JCE $254 |
| Clawbacks / gross-ups | Not disclosed for directors | None disclosed |
Other Directorships & Interlocks
| Company/Institution | Type | Role | Tenure | Potential Interlock/Conflict |
|---|---|---|---|---|
| Travelers Canada subsidiaries | Insurance | Director | 2013–2017 | Historical role; no current related-party transactions disclosed for Wolff . |
| New York-Presbyterian Hospital | Nonprofit | Trustee | Since 2005 | No fund-related conflict disclosed . |
| John A. Hartford Foundation | Nonprofit | Trustee; former Chair | Since 2004 | No fund-related conflict disclosed . |
Expertise & Qualifications
- Governance and fiduciary advisory expertise from >30 years of M&A legal practice; board and senior management counsel on U.S. and international corporate, securities, regulatory, and strategic matters .
- Education: BA, Mt. Holyoke College; JD, Case Western Reserve University School of Law .
- Committee leadership: Chair of Compliance Committee overseeing risk, liquidity, leverage, derivatives, and enterprise operational risks for the Funds .
- Not designated an “audit committee financial expert” (committee has four designated experts: Moschner, Nelson, Starr, Young) .
Equity Ownership
- Ownership guideline: Nuveen Funds boards expect each Board Member to invest at least one year of compensation in funds within the complex .
- JCE-specific beneficial ownership (as of Dec 31, 2024): Dollar range $0; shares owned 0 .
- Aggregate holdings across the registered investment companies overseen: “Over $100,000” for Wolff .
- Ownership concentration: As of Feb 18, 2025, each Board Member’s individual holdings in each Fund were <1% of outstanding shares .
| Measure | JCE (Core Equity Alpha) | Fund Complex Aggregate |
|---|---|---|
| Dollar range (Dec 31, 2024) | $0 | Over $100,000 |
| Shares owned (Dec 31, 2024) | 0 | N/A (aggregate dollar range only) |
| % of outstanding | <1% (individual) | N/A |
Governance Assessment
-
Strengths:
- Independent director with substantial governance and legal credentials; chairs Compliance Committee overseeing key fund risk domains .
- Solid engagement: attended ≥75% of Board/committee meetings; JCE held 5 regular and 9 special Board meetings, indicating active oversight cadence .
- Transparent, cash-based director pay; meaningful committee leadership/memberships aligning incentives to oversight workload; total paid $535,644 across complex, with JCE allocation $724 .
-
Alignment:
- Nuveen governance principle expects investment equal to one year’s compensation in complex funds; Wolff reports “Over $100,000” aggregate holdings across the complex, consistent with the principle, though JCE-specific holdings were $0 as of 12/31/2024 .
-
RED FLAGS / Watch items:
- $0 direct holding in JCE may be noted by some investors seeking tighter fund-specific alignment, even as aggregate complex holdings exceed $100,000 .
- Not designated an Audit Committee “financial expert” (though on Audit Committee), placing more weight on other designated experts for audit oversight .
-
Conflicts/related-party:
- No related-party transactions disclosed for Wolff; directors are independent of TIAA/Nuveen; Section 16(a) filings were compliant in the last fiscal year .
- Ownership in adviser-related companies table shows entries for other directors (e.g., Kenny), not Wolff .
-
Committee effectiveness signals:
- Compliance Committee charter includes broad risk oversight (liquidity, leverage, derivatives, enterprise operational risk); quarterly CCO reports and private sessions support robust compliance governance under Wolff’s chairship .
-
Compensation structure signals:
- Shift from per-meeting fees (2023) to higher annual retainers and committee retainers (2024–2025) reflects institutionalization of workload-based compensation; chair premiums for compliance and other committees emphasize accountability in oversight roles .